ArticleFrontiers in pediatrics2025
Case Report: From diagnosis to therapy: a lung ultrasound-driven precision strategy for neonatal atelectasis management.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anaesthesia-induced atelectasis in a rat model (Frontiers in veterinary science · 2025Article
- Lung ultrasound score ≥ 6 predicts surfactant administration decisions in meconium aspiration syndrome: a multicenter prospective study.Jornal de pediatriaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine the clinical value of lung ultrasound (LUS) in the individualized management of neonatal atelectasis and assess its effectiveness in directing condition-specific treatment strategies. Methods: Three neonatal atelectasis cases with differing causes, pneumonia, pulmonary hemorrhage, and meconium aspiration syndrome, were treated with LUS-guided, personalized interventions. These included ultrasound-directed airway clearance, selective bronchoalveolar lavage, and high-frequency chest wall oscillation. Results: LUS enabled continuous, real-time assessment of atelectasis severity and distinct pathological signs such as hepatization and the shred sign. This imaging guidance allowed targeted therapies that shortened hospitalization by an average of 40%. In all cases, lung re-expansion was achieved without adverse events. Conclusion: Due to its lack of radiation, high sensitivity, and real-time feedback, LUS offers a valuable tool for guiding individualized, etiology-specific therapies in neonatal atelectasis. It presents a clinically adaptable approach for optimizing outcomes in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.